Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.

Tumour cells exploit both genetic and adaptive means to survive and proliferate in hypoxic microenvironments, resulting in the outgrowth of more aggressive tumour cell clones. Direct measurements of tumour oxygenation, and surrogate markers of the hypoxic response in tumours (for instance, hypoxia i...

Full description

Bibliographic Details
Main Authors: Jubb, A, Buffa, F, Harris, A
Format: Journal article
Language:English
Published: 2010
_version_ 1797090509381959680
author Jubb, A
Buffa, F
Harris, A
author_facet Jubb, A
Buffa, F
Harris, A
author_sort Jubb, A
collection OXFORD
description Tumour cells exploit both genetic and adaptive means to survive and proliferate in hypoxic microenvironments, resulting in the outgrowth of more aggressive tumour cell clones. Direct measurements of tumour oxygenation, and surrogate markers of the hypoxic response in tumours (for instance, hypoxia inducible factor-1alpha, carbonic anhydrase 9 and glucose transporter-1) are well-established prognostic markers in solid cancers. However, individual markers do not fully capture the complex, dynamic and heterogeneous hypoxic response in cancer. To overcome this, expression profiling has been employed to identify hypoxia signatures in cohorts or models of human cancer. Several of these hypoxia signatures have demonstrated prognostic significance in independent cancer datasets. Nevertheless, individual hypoxia markers have been shown to predict the benefit from hypoxia-modifying or anti-angiogenic therapies. This review aims to discuss the clinical impact of translational work on hypoxia markers and to explore future directions for research in this area.
first_indexed 2024-03-07T03:19:38Z
format Journal article
id oxford-uuid:b6feaeaf-3153-46b8-bfd2-b2abf8df944b
institution University of Oxford
language English
last_indexed 2024-03-07T03:19:38Z
publishDate 2010
record_format dspace
spelling oxford-uuid:b6feaeaf-3153-46b8-bfd2-b2abf8df944b2022-03-27T04:45:06ZAssessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b6feaeaf-3153-46b8-bfd2-b2abf8df944bEnglishSymplectic Elements at Oxford2010Jubb, ABuffa, FHarris, ATumour cells exploit both genetic and adaptive means to survive and proliferate in hypoxic microenvironments, resulting in the outgrowth of more aggressive tumour cell clones. Direct measurements of tumour oxygenation, and surrogate markers of the hypoxic response in tumours (for instance, hypoxia inducible factor-1alpha, carbonic anhydrase 9 and glucose transporter-1) are well-established prognostic markers in solid cancers. However, individual markers do not fully capture the complex, dynamic and heterogeneous hypoxic response in cancer. To overcome this, expression profiling has been employed to identify hypoxia signatures in cohorts or models of human cancer. Several of these hypoxia signatures have demonstrated prognostic significance in independent cancer datasets. Nevertheless, individual hypoxia markers have been shown to predict the benefit from hypoxia-modifying or anti-angiogenic therapies. This review aims to discuss the clinical impact of translational work on hypoxia markers and to explore future directions for research in this area.
spellingShingle Jubb, A
Buffa, F
Harris, A
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title_full Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title_fullStr Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title_full_unstemmed Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title_short Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
title_sort assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
work_keys_str_mv AT jubba assessmentoftumourhypoxiaforpredictionofresponsetotherapyandcancerprognosis
AT buffaf assessmentoftumourhypoxiaforpredictionofresponsetotherapyandcancerprognosis
AT harrisa assessmentoftumourhypoxiaforpredictionofresponsetotherapyandcancerprognosis